Stacy Loeb, MD discusses how the decision for prostate cancer screening should be an individual one, rather than population-based. Individual risk factors including age, general health, family history, etc are all important to consider. While the results from the ERSPC trial do show better outcomes for those who have undergone a PSA screening, patients should consider the risks before testing.
References:
N Engl J Med 2009; 360:1320-1328
Faculty and Financial Disclosures:
Dr. Loeb has no relevant financial disclosures.
